Copy
hypertension.cochrane.org
View this email in your browser
Trusted evidence. Informed decisions. Better health.

Issue 11, Summer 2020

New time course review

Time course for blood pressure lowering of beta‐blockers with partial agonist activity

Key results:

  • We identified seven studies, involving 121 participants, that studied three of the six beta‐blockers with partial agonist activity (acebutolol, pindolol, and bopindolol).
  • We found that these beta‐blockers lowered blood pressure and heart rate more during the day and evening than at night.
  • Currently, we do not know the benefits and harms of this pattern of blood pressure lowering, such as its impact on reducing stroke and heart disease.

Cochrane Hypertension 2019 Impact Factor

The 2019 Journal Citation Report has just been released by Clarivate Analytics, and we are pleased to announce that the Journal Impact Factor (IF) for Cochrane Hypertension (HTN) increased from 5.412 to 8.625

The IF is calculated by taking the total number of citations in a given year to all Cochrane HTN Reviews published in the past 2 years and dividing that number by the total number of Reviews published in the past 2 years. It is a useful metric for measuring the strength of a journal by how often its publications are cited in scholarly articles. 

Other highlights of the 2019 Journal Impact Factor report:

  • 16 Cochrane HTN reviews published in 2017 and 2018 were cited 138 times in 2019 (record number of citations for our group, first time over 100)
  • Cochrane Hypertension would be ranked among the top 10 of journals publishing in the same category (the journal Peripheral Vascular Disease is the category median with an IF of 2.669; the journal ranked 10th is Current Atherosclerosis Reports with an IF of 4.608; the highest ranked journal in this category is Circulation with an IF of 23.603

Our latest reviews

As of September 2020, The Cochrane Library contains 75 reviews and 39 protocols under Cochrane Hypertension and 39 additional titles have been registered by the group for authors intending to undertake systematic reviews.

Latest protocols [P], reviews [R] and updates [U]:

Methods Speaker Series - Register now!
UBC Therapeutics Initiative Methods Speaker Series events are free of charge and feature expert speakers presenting a wide range of research methods topics.  Presentations are recorded and the video recordings are posted online. A list of past and future research methods topics is available here

Next presentation:

Careful and kind diabetes care
Expert speaker: Dr. Victor Montori
Registration/info
https://bit.ly/2RtvRdF

Wednesday 23 September
19:00 Vancouver
22:00 New York
12:00 Sydney (24 Sep)
Cochrane Interactive Learning
Developed by experts, this course provides over 10 hoursof self-directed learning on conducting a complete systematic review process for both new and experienced review authors
 
Cochrane Interactive Learning: 
https://training.cochrane.org/interactivelearning

 
Are you following us on Twitter?
Risk of Bias (ROB 2) webinar series
Sign up for upcoming Cochrane Learning Live webinars on Risk of Bias 2 (RoB 2)
https://training.cochrane.org/rob-2-learning-live-webinar-series

September 17, 2020
RoB 2 Domain 4: Bias in measurement of the outcome

October 15, 2020
RoB 2 Domain 5: Bias in selection of the reported results

More upcoming sessions here:
https://training.cochrane.org/rob-2-learning-live-webinar-series


Watch previously recorded sessions:

3: Bias due to missing outcome data [click for recording]

2: Bias due to deviations from the intended interventions [click for recording]

1: Bias arising from the randomisation proces[click for recording]

Intro: [click for recording]

New international HTA database launched

The International Network of Agencies for Health Technology Assessment (INAHTA) has launched a new and improved international HTA database providing a single platform for retrieving records of completed and ongoing health technology assessments (HTAs) from around the world. The database was previously produced by the CRD and this new rebuild by INAHTA includes:

  • Streamlined and strengthened search function
  • Expanded records containing more abstract information to improve utility and searchability
  • Records from 120 HTA producers including INAHTA member agencies and other organizations
  • Filters for refinement of search results
Website
Website
Twitter
Twitter
Facebook
Facebook
Email
Email

 






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Cochrane Hypertension · 2176 Health Sciences Mall · Vancouver, BC V6T 1Z3 · Canada

Email Marketing Powered by Mailchimp